Home | April 2012News | Xybion announces a major biotechnology company licenses Pristima for early discovery pathology data management |
|
|
Xybion announces a major biotechnology company licenses Pristima for early discovery pathology data management
- Xybion announces a major biotechnology company licenses Pristima for early discovery pathology data management
- April 24, 2012
-
Xybion Corporation announced that its Pristima Preclinical Software suite has been selected as the primary preclinical platform for early-stage drug discovery pathology data management by a Top-5 global biotech firm.
CEDAR KNOLLS, NJ: Xybion Corporation announced that its Pristima Preclinical Software suite has been selected as the primary preclinical platform for early-stage drug discovery pathology data management by a Top-5 global biotech firm. The new Xybion client becomes the third major biotech laboratory in the Cambridge Massachusetts Biotechnology Research hub to choose Pristima Suite as the centerpiece for its drug discovery and early stage development efforts.
This leading biote...
- View more at: http://www.1888pressrelease.com/preclinical-software/xybion/xybion-announces-a-major-biotechnology-company-licenses-pris-pr-392194.html
|